Gadi Gilam1, John A Sturgeon2, Dokyoung S You1, Ajay D Wasan3, Beth D Darnall1, Sean C Mackey1. 1. Division of Pain Medicine, Department of Anesthesiology, Perioperative, and Pain Medicine, Stanford University School of Medicine, Palo Alto, California. 2. Center for Pain Relief, Department of Anesthesiology and Pain Medicine, University of Washington School of Medicine, Seattle, Washington. 3. Division of Chronic Pain, Department of Anesthesiology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Abstract
OBJECTIVE: Increased opioid prescription to relieve pain among patients with chronic pain is associated with increased risk for misuse, potentially leading to substance use disorders and overdose death. We aimed to characterize the relative importance and identify the most significant of several potential risk factors for the severity of self-reported prescribed opioid misuse behaviors. METHODS: A sample of 1,193 patients (mean age ± SD = 50.72 ± 14.97 years, 64.04% female) with various chronic pain conditions completed a multidimensional registry assessing four pain severity measures and 14 physical, mental, and social health status factors using the National Institutes of Health's Patient-Reported Outcomes Measurement Information System (PROMIS). A validated PROMIS measure of medication misuse was completed by 692 patients who endorsed currently taking opioid medication. Patients taking opioid medications were compared across all measures with those who do not take opioid medications. Subsequently, a data-driven regression analysis was used to determine which measures best explained variability in severity of misuse. We hypothesized that negative affect-related factors, namely anxiety, anger, and/or depression, would be key predictors of misuse severity due to their crucial role in chronic pain and substance use disorders. RESULTS: Patients taking opioid medications had significantly greater impairment across most measures. Above and beyond demographic variables, the only and most significant predictors of prescribed opioid misuse severity were as follows: anxiety (β = 0.15, P = 0.01), anger (β = 0.13, P = 0.02), Pain Intensity-worst (β = 0.09, P = 0.02), and depression (β = 0.13, P = 0.04). CONCLUSIONS: Findings suggest that anxiety, anger, and depression are key factors associated with prescribed opioid misuse tendencies in patients with chronic pain and that they are potential targets for therapeutic intervention.
OBJECTIVE: Increased opioid prescription to relieve pain among patients with chronic pain is associated with increased risk for misuse, potentially leading to substance use disorders and overdose death. We aimed to characterize the relative importance and identify the most significant of several potential risk factors for the severity of self-reported prescribed opioid misuse behaviors. METHODS: A sample of 1,193 patients (mean age ± SD = 50.72 ± 14.97 years, 64.04% female) with various chronic pain conditions completed a multidimensional registry assessing four pain severity measures and 14 physical, mental, and social health status factors using the National Institutes of Health's Patient-Reported Outcomes Measurement Information System (PROMIS). A validated PROMIS measure of medication misuse was completed by 692 patients who endorsed currently taking opioid medication. Patients taking opioid medications were compared across all measures with those who do not take opioid medications. Subsequently, a data-driven regression analysis was used to determine which measures best explained variability in severity of misuse. We hypothesized that negative affect-related factors, namely anxiety, anger, and/or depression, would be key predictors of misuse severity due to their crucial role in chronic pain and substance use disorders. RESULTS:Patients taking opioid medications had significantly greater impairment across most measures. Above and beyond demographic variables, the only and most significant predictors of prescribed opioid misuse severity were as follows: anxiety (β = 0.15, P = 0.01), anger (β = 0.13, P = 0.02), Pain Intensity-worst (β = 0.09, P = 0.02), and depression (β = 0.13, P = 0.04). CONCLUSIONS: Findings suggest that anxiety, anger, and depression are key factors associated with prescribed opioid misuse tendencies in patients with chronic pain and that they are potential targets for therapeutic intervention.
Authors: Alicia Grattan; Mark D Sullivan; Kathleen W Saunders; Cynthia I Campbell; Michael R Von Korff Journal: Ann Fam Med Date: 2012 Jul-Aug Impact factor: 5.166
Authors: Karon F Cook; Winnie Dunn; James W Griffith; M Tracy Morrison; Jennifer Tanquary; Dory Sabata; David Victorson; Leeanne M Carey; Joy C Macdermid; Brian J Dudgeon; Richard C Gershon Journal: Neurology Date: 2013-03-12 Impact factor: 9.910
Authors: Ajay D Wasan; Stephen F Butler; Simon H Budman; Kathrine Fernandez; Roger D Weiss; Shelly F Greenfield; Robert N Jamison Journal: Clin J Pain Date: 2009 Mar-Apr Impact factor: 3.442
Authors: Beatrice Setnik; Carl L Roland; Kenneth W Sommerville; Glenn C Pixton; Robert Berke; Anne Calkins; Veeraindar Goli Journal: J Pain Res Date: 2015-07-09 Impact factor: 3.133
Authors: Anna Parisi; Hannah Louise Landicho; Justin Hudak; Siri Leknes; Brett Froeliger; Eric L Garland Journal: Drug Alcohol Depend Date: 2022-02-24 Impact factor: 4.852
Authors: Kristen Hymel Scherrer; Maisa S Ziadni; Jiang-Ti Kong; John A Sturgeon; Vafi Salmasi; Juliette Hong; Eric Cramer; Abby L Chen; Teresa Pacht; Garrick Olson; Beth D Darnall; Ming-Chih Kao; Sean Mackey Journal: Pain Rep Date: 2021-01-15
Authors: Dokyoung S You; Maisa S Ziadni; Gabrielle Hettie; Beth D Darnall; Karon F Cook; Michael R Von Korff; Sean C Mackey Journal: Front Pain Res (Lausanne) Date: 2022-04-08
Authors: Bryan Cortez; Elaine Coughlan-Gifford; Rachel Grashow; Adam S Tenforde; Jillian Baker; Aaron L Baggish; Alvaro Pascual-Leone; Lee M Nadler; Frank E Speizer; Herman A Taylor; Marc G Weisskopf; Ross Zafonte Journal: PM R Date: 2021-05-13 Impact factor: 2.218